Inspire Medical Systems (NYSE:INSP) Reaches New 1-Year Low – Time to Sell?

Inspire Medical Systems, Inc. (NYSE:INSP) shares reached a new 52-week low on Tuesday . The company traded as low as $43.03 and last traded at $43.3570, with a volume of 918050 shares changing hands. The stock had previously closed at $44.26.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on INSP shares. Wells Fargo & Company cut their price objective on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a report on Tuesday, May 5th. Piper Sandler cut shares of Inspire Medical Systems from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $85.00 to $55.00 in a report on Tuesday, May 5th. Zacks Research cut shares of Inspire Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 14th. Weiss Ratings cut shares of Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Finally, Mizuho cut their price objective on shares of Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating for the company in a report on Tuesday, May 5th. Four investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Inspire Medical Systems presently has an average rating of “Hold” and an average target price of $85.00.

Inspire Medical Systems Stock Down 2.0%

The company’s 50-day moving average price is $55.22 and its 200-day moving average price is $78.44. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 9.66, a price-to-earnings-growth ratio of 4.57 and a beta of 0.83.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The business had revenue of $204.58 million for the quarter, compared to analyst estimates of $200.04 million. During the same quarter last year, the business earned $0.10 earnings per share. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Analysts predict that Inspire Medical Systems, Inc. will post 0.91 earnings per share for the current fiscal year.

Institutional Trading of Inspire Medical Systems

Several institutional investors have recently modified their holdings of the stock. Xponance Inc. grew its position in shares of Inspire Medical Systems by 2.9% in the third quarter. Xponance Inc. now owns 4,177 shares of the company’s stock valued at $310,000 after purchasing an additional 116 shares during the period. Daiwa Securities Group Inc. grew its position in shares of Inspire Medical Systems by 38.7% in the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after purchasing an additional 130 shares during the period. State of Wyoming grew its position in shares of Inspire Medical Systems by 31.5% in the fourth quarter. State of Wyoming now owns 731 shares of the company’s stock valued at $67,000 after purchasing an additional 175 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Inspire Medical Systems by 84.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after purchasing an additional 205 shares during the period. Finally, Apollon Wealth Management LLC grew its position in shares of Inspire Medical Systems by 5.6% in the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after purchasing an additional 212 shares during the period. Institutional investors and hedge funds own 94.91% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.